Potent and selective pyridone BTK inhibitors with activity against mutant forms of BTK

被引：0
|
作者：
Crawford, James [1 ]
机构：
[1] Genentech Inc, San Francisco, CA USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2015年 / 249卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
230
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Potent and selective pyridone BTK inhibitors with an induced fit binding mode and activity vs. mutant forms of BTK
    Crawford, James J.
    Johnson, Adam
    Wei, BinQing
    Ortwine, Daniel F.
    Kohli, Pawan Bir
    Young, Wendy B.
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 248
  • [2] Optimization of a novel piperazinone series as potent selective peripheral covalent BTK inhibitors
    Ma, Bin
    Metrick, Claire M.
    Gu, Chungang
    Hoemberger, Marc
    Bajrami, Bekim
    Bame, Eris
    Huang, Jiansheng
    Mingueneau, Michael
    Murugan, Paramasivam
    Santoro, Joseph C.
    Tang, Hao
    Wang, Ti
    Hopkins, Brian T.
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2022, 60
  • [3] Purine derivatives as potent BTK inhibitors for autoimmune diseases
    Shi, Qing
    Liu, Chunjian
    Lin, James
    Dyckman, Alaric J.
    Li, Hedy
    Vandevier, Lauren E.
    Cavallaro, Cullen
    Spergel, Steven
    Burke, James R.
    Tebben, Andrew
    Strnad, Joann
    Surti, Neha
    Muckelbauer, Jodi K.
    Mcintyre, Kim
    Leftheris, Katerina
    Carter, Percy H.
    Tino, Joseph
    Delucca, George V.
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 242
  • [4] REDX08608, a Novel, Potent and Selective, Reversible BTK Inhibitor with Efficacy and Equivalent Potency Against Wild-Type and Mutant C481S BTK
    Guisot, Nicolas E. S.
    Best, Stuart A.
    Wright, Victoria
    Thomason, Andrew
    Woyach, Jennifer A.
    Mantel, Rose
    McClanahan, Fabienne
    Abet, Valentina
    Castagna, Diana
    Cousin, Peggy
    Emmerich, Juliette
    Ho, Kelvin
    Kelly, James Russell
    King-Tours, James
    Lyons, Kristina
    Muller, Melanie
    Refuerzo, Julienne
    Sargent, Louise
    Talab, Fatima
    Bingham, Matilda
    Phillips, Caroline
    Armer, Richard
    [J]. BLOOD, 2016, 128 (22)
  • [5] Discovery of pyrazolopyrimidine derivatives as potent BTK inhibitors with effective anticancer activity in MCL
    Ran, Fansheng
    Liu, Yang
    Liu, Meixia
    Zhang, Daoguang
    Wang, Peng
    Dong, Junze
    Tang, Wendi
    Zhao, Guisen
    [J]. BIOORGANIC CHEMISTRY, 2019, 89
  • [6] Nicotinamide derivatives as potent BTK inhibitors for autoimmune diseases
    De Lucca, George V.
    Shi, Qing
    Liu, Chunjian
    Tebben, Andrew
    Strnad, Joann
    Surti, Neha
    Muckelbauer, Jodi K.
    Mcintyre, Kim
    Burke, James R.
    Leftheris, Katerina
    Carter, Percy H.
    Tino, Joseph
    Chang, Chiehying
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 242
  • [7] Discovery of a novel series of pyridine and pyrimidine carboxamides as potent and selective covalent inhibitors of Btk
    Caldwell, Richard
    Liu-Bujalski, Lesley
    Qiu, Hui
    Mochalkin, Igor
    Jones, Reinaldo
    Neagu, Constantin
    Goutopoulos, Andreas
    Grenningloh, Roland
    Johnson, Theresa
    Sherer, Brian
    Gardberg, Anna
    Follis, Ariele Viacava
    Morandi, Federica
    Head, Jared
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2018, 28 (21) : 3419 - 3424
  • [8] Discovery of potent, highly selective covalent irreversible BTK inhibitors from a fragment hit
    Qiu, Hui
    Liu-Bujalski, Lesley
    Caldwell, Richard D.
    Follis, Ariele Viacava
    Gardberg, Anna
    Goutopoulos, Andreas
    Grenningloh, Roland
    Head, Jared
    Johnson, Theresa
    Jones, Reinaldo
    Mochalkin, Igor
    Morandi, Federica
    Neagh, Constantin
    Sherer, Brian
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2018, 28 (17) : 2939 - 2944
  • [9] ABBV-101, a highly potent and selective clinical stage Bruton tyrosine kinase degrader, overcomes BTK mutation-induced resistance to BTK inhibitors
    Pan, Chin
    Riehm, Jacob
    Gururaja, Tarikere L.
    Li, Haiyan
    Nguyen, Henry
    Zhai, Yongjiao
    Xie, Xiaoping
    Ding, Rong-Xian
    Matthew, Rebecca
    Hoh, Hana Y.
    Jia, Zhaozhong J.
    Liu, Bo
    Shu, Cassandra P.
    Stevenson, Claudina A.
    Will, Christine
    Innocenti, Federico
    Assaily, Wissam
    Lam, Lloyd T.
    Rivkin, Alexey
    [J]. CANCER RESEARCH, 2024, 84 (06)
  • [10] Hnd-01: a potent inhibitor of wild type mutant BTK
    Zhang, Jing
    Samatar, Ahmed A.
    Tan, Yue
    Pi, Shiqing
    Zhou, Zhigang
    Xu, Yan
    Yang, Daihong
    [J]. CANCER RESEARCH, 2023, 83 (07)
12345